FY2026 EPS Estimates for Novartis Lifted by Erste Group Bank

Novartis AG (NYSE:NVS) – Equities researchers at Erste Group Bank boosted their FY2026 earnings estimates for shares of Novartis in a research note issued to investors on Thursday, October 8th. Erste Group Bank analyst H. Engel now anticipates that the company will post earnings per share of $9.24 for the year, up from their previous forecast of $9.14. The consensus estimate for Novartis’ current full-year earnings is $8.91 per share.

Novartis (NYSE:NVS) last released its earnings results on Tuesday, June 30th. The company reported $2.41 earnings per share (EPS) for the quarter. The company had revenue of $14.95 billion during the quarter. Novartis had a return on equity of 38.56% and a net margin of 23.29%.

NVS has been the subject of a number of other research reports. Royal Bank Of Canada initiated coverage on Novartis in a research note on Tuesday, September 8th. They issued a “sector perform” rating for the company. HSBC upgraded Novartis from a “reduce” rating to a “hold” rating and lifted their target price for the stock from $123.00 to $136.00 in a research note on Thursday, September 10th. Morgan Stanley reissued an “overweight” rating and issued a $156.00 price target on shares of Novartis in a report on Tuesday, October 6th. Weiss Ratings reissued a “buy (b)” rating on shares of Novartis in a report on Friday, July 24th. Finally, JPMorgan Chase & Co. restated a “buy” rating on shares of Novartis in a research report on Sunday, August 9th. Six equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $145.60.

Novartis Stock Up 3.2%

NVS stock opened at $146.94 on Tuesday. The stock’s fifty day simple moving average is $148.54 and its two-hundred day simple moving average is $150.45. The company has a current ratio of 0.86, a quick ratio of 0.67 and a debt-to-equity ratio of 0.89. Novartis has a 1-year low of $121.57 and a 1-year high of $170.46. The stock has a market cap of $280.38 billion, a P/E ratio of 22.16, a P/E/G ratio of 2.58 and a beta of 0.41.

Hedge Funds Weigh In On Novartis

Several institutional investors have recently bought and sold shares of the company. Archer Investment Corp increased its stake in Novartis by 93.0% in the 1st quarter. Archer Investment Corp now owns 166 shares of the company’s stock worth $25,000 after acquiring an additional 80 shares during the last quarter. Highland Investment Advisors LLC bought a new stake in shares of Novartis during the 2nd quarter valued at about $25,000. Evolution Wealth Management Inc. boosted its position in shares of Novartis by 552.0% during the 2nd quarter. Evolution Wealth Management Inc. now owns 163 shares of the company’s stock valued at $26,000 after acquiring an additional 138 shares during the last quarter. Atlatl Advisers LLC purchased a new position in shares of Novartis during the second quarter worth about $26,000. Finally, Silicon Valley Capital Partners grew its holdings in shares of Novartis by 519.4% during the second quarter. Silicon Valley Capital Partners now owns 192 shares of the company’s stock worth $30,000 after purchasing an additional 161 shares in the last quarter. Hedge funds and other institutional investors own 13.12% of the company’s stock.

Novartis Company Profile

Novartis AG is a Switzerland-based pharmaceutical company focused on the discovery, development and commercialization of innovative medicines. The company’s research and commercial activities center on cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology and hematology. Its portfolio includes prescription medicines such as Entresto, Cosentyx, Kesimpta, Kisqali, Pluvicto, Leqvio and Jakavi, as well as other therapies for serious and chronic conditions.

Novartis serves patients and healthcare providers in markets worldwide, with operations spanning North America, Europe, Asia and other international regions.